People

Charles Carter

Chief financial officer of Ovid Therapeutics, promoted in July 2026 after joining in 2024 to lead finance and financial planning. Previously held CFO positions at CERo Therapeutics, iCAD and GI Dynamics, with earlier roles at Transkaryotic Therapies and Mercer Management Consulting.